Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
American Heart Journal|December 7, 2018
The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial designKristina Lambrakis, John K French, Ian A Scott, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 17, 2008
The endogenous brain constituent N-arachidonoyl L-serine is an activator of large conductance Ca2+-activated K+ channelsGrzegorz Godlewski, László Offertáler, Douglas Osei-Hyiaman, et al.
Heart (British Cardiac Society)|October 27, 2006
Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroupsAdrián V Hernández, Cynthia M Westerhout, Ewout W Steyerberg, et al.
Journal of the American College of Cardiology|June 4, 2011
Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysisGeorge D Dangas, Roxana Mehran, Eugenia Nikolsky, et al.
Neurobiology of Disease|August 12, 2010
Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder?Paul J Fitzgerald, Chris Barkus, Michael Feyder, et al.
Chemistry & Biology|November 25, 2010
Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effectsGrzegorz Godlewski, Shakiru O Alapafuja, Sándor Bátkai, et al.
Lancet (London, England)|January 29, 2002
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trialsEric Boersma, Robert A Harrington, David J Moliterno, et al.
The New England Journal of Medicine|June 24, 2005
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or bothScott D Solomon, Steve Zelenkofske, John J V McMurray, et al.
JACC. Cardiovascular Interventions|June 25, 2011
Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trialsRoxana Mehran, Stuart Pocock, Eugenia Nikolsky, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 17, 2008
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndromeMirjam Christ-Crain, Blerina Kola, Francesca Lolli, et al.
Pageof 18